Mark E Molitch, MD did housestaff training at the Hospital of the University of Pennsylvania and an Endocrine Fellowship at the UCLA-Harbor General Hospital. Prior to joining the faculty at Northwestern in 1984, Dr. Molitch was at Tufts University School of Medicine in Boston, Massachusetts.
Dr. Molitch has participated in clinical research for many years, focusing on the pathogenesis of pituitary tumors and their treatment and the pathogenesis and treatment of diabetic kidney disease. He has participated in the development of most of the medical treatments for pituitary tumors. He has also participated in many NIH-sponsored multicenter trials, including the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study, the Diabetes Prevention Program, and the Bypass Angioplasty Revascularization Investigation 2 Diabetes Trial, the Testosterone Trial.
In addition to editing eight books and journal volumes, Dr. Molitch has authored or coauthored more than 400 original papers, review articles, book chapters, case reports and other publications. These include the Guidelines for the evaluation and treatment of Adult Growth Hormone Deficiency, of Pituitary Incidentalomas, and of Acromegaly (pending) of The Endocrine Society and of Prolactinomas of The Pituitary Society, the Standards of Care (twice) and the Diagnosis and Management of Diabetic Kidney Disease of the American Diabetes Association, and the Diagnosis and Management of Diabetic Kidney Disease of the National Kidney Foundation.
In 1997, Dr. Molitch was named "Outstanding Physician Educator in the Field of Diabetes" by the American Diabetes Association and he has been awarded the "Distinguished Educator Award" of The Endocrine Society for 2013. He was elected to the Council of The Endocrine Society from 2007 to 2010 and just completed a 3 year term as the Chair of The Endocrine Society’s Clinical Endocrinology Update (CEU) in 2012. He is also the President of The Pituitary Society for 2012-2013.